Aclaris Therapeutics, Inc. (ACRS) News
Track canonical SquawkNews coverage tagged to ACRS, Aclaris Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Aclaris Therapeutics to participate in Sept. 10 Cantor healthcare conference
Aclaris Therapeutics said its Chief Exec officer will present at the 2026 Cantor Global Healthcare Conference on Thursday, Sept. 10, 2026 at 2:45 PM ET.
EQUITY | Sep 03, 2026, 12:07 PM UTC
L
Aclaris Therapeutics to participate in 2026 Cantor healthcare conference
Aclaris Therapeutics (ACRS) plans to participate in the 2026 Cantor Global Healthcare Conference.
EQUITY | Sep 03, 2026, 12:00 PM UTC
L
Aclaris Therapeutics started at Buy by Canaccord Genuity
Aclaris Therapeutics (ACRS) was initiated at Buy by Canaccord Genuity.
EQUITY | Sep 01, 2026, 05:56 PM UTC
L
ACRS - Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
ACRS - Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
EARNINGS | Aug 06, 2026, 10:59 AM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
M
SLBT Falls 11.4%
SL Science Holding Ltd shares fell sharply in pre-market trading after reporting a 35% decline in net revenue and a wider net loss for the year
EARNINGS | Jun 22, 2026, 12:03 PM UTC